DATE [JIAYUAN.COM INTERNATIONAL] F-1/A: (Original Filing)

[AMENDMENT NO. 3 TO Form F-1 REGISTRATION STATEMENT Jiayuan.com International Ltd. Not Applicable Cayman Islands 7371 Not Applicable Room 1005, Changxin Building CT Corporation System (Name, address, including zip code, and telephone number, including area code, of agent for service) Copies to: David S. Wang, Esq. David T. Zhang, Esq. Approximate date of commencement of proposed sale to the public:] [L&W Draft May 5, 2011 JIAYUAN.COM INTERNATIONAL LTD. 10,650,000 Ordinary Shares (par value US$0.001 per share ) Each represented by American Depositary Shares UNDERWRITING AGREEMENT May [ ], 2011 Citigroup Global Markets Inc. 388 Greenwich Street New York, New York 10013 and Merrill Lynch, Pierce, Fenner & Smith Incorporated One Bryant Park New York, New York 10036 As Representatives of] [JIAYUAN.COM INTERNATIONAL LTD. May , 2011 Merrill Lynch, Pierce, Fenner & Smith Incorporated One Bryant Park New York, New York 10036 Re: Jiayuan.com International Ltd. Reserved Share Program Ladies and Gentlemen: Reference is made to the Underwriting Agreement dated May , 2011 (the “Underwriting Agreement”) among Jiayuan.com International Ltd. (the “Company”), the Selling Shareholders and the Underwriters listed in Schedule] [LEGAL OPINION To: JIAYUAN.COM INTERNATIONAL LTD. Room 1005, Changxin Building May 6, 2011 Dear Sir/Madam: 1. PRC Opinion We are lawyers qualified in the People’s Republic of China (the “ 2. Company Offering ADSs Ordinary Shares Offered Securities” Registration Statement SEC We act as the PRC counsel to Jiayuan.com International Ltd. (the “ 3. Documents In so acting, we have] [CONTRACT ASSIGNMENT AGREEMENT Agreement This CONTRACT ASSIGNMENT AGREEMENT (this “ BEIJING MIYUAN INFORMATION TECHNOLOGY CO., LTD. Assignor (the “ MIYUAN (SHANGHAI) INFORMATION TECHNOLOGY CO., LTD. Assignee (the “ BEIJING HUAQIANSHU INFORMATION TECHNOLOGY CO., LTD. Beijing Huaqianshu (“ HAIYAN GONG , a Chinese citizen; YONGQIANG QIAN , a Chinese citizen; XU LIU, a Chinese citizen; CHENG LI , a Chinese citizen;] [CONTRACT ASSIGNMENT AGREEMENT Agreement This CONTRACT ASSIGNMENT AGREEMENT (this “ BEIJING MIYUAN INFORMATION TECHNOLOGY CO., LTD. Assignor (the “ MIYUAN (SHANGHAI) INFORMATION TECHNOLOGY CO., LTD. Assignee (the “ BEIJING SHIJI XIQUE INFORMATION TECHNOLOGY CO., LTD. Shiji Xique (“ HAIYAN GONG , a Chinese citizen; YONGQIANG QIAN , a Chinese citizen; XU LIU, a Chinese citizen; CHENG LI , a Chinese] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the use in this Registration Statement on Form F-1/A of Jiayuan.com International Ltd. of our report dated March 8, 2011, except for Note 19(c), (e) and (f) which are as of April 20, 2011, relating to the consolidated financial statements of Jiayuan.com International Ltd., which appears in such Registration] [LEGAL OPINION To: JIAYUAN.COM INTERNATIONAL LTD. Room 1005, Changxin Building No. 39 Anding Road, Chaoyang District Beijing 100029 the People’s Republic of China May 6, 2011 Dear Sir/Madam: 1. PRC Opinion We are lawyers qualified in the People’s Republic of China (the “ 2. Company Offering ADSs Ordinary Shares Offered Securities” Registration Statement SEC We act as the PRC counsel]

CNR [CHINA METRO-RURAL] 6-K: China Metro-Rural Holdings Limited CNR Announces Pricing of

[China Metro-Rural Holdings Limited CNR Announces Pricing of Units Offering • • If for the fiscal year ended March 31, 2012 the Company’s adjusted EBITDA: ¡ ¡ ¡ The Company has granted the underwriter an option for 45 days to purchase up to an additional 227,696 units. The offering is subject to customary closing conditions and is expected to close] [CHINA METRO-RURAL HOLDINGS LIMITED By Sio Kam Seng]

By | 2016-03-20T09:42:19+00:00 May 6th, 2011|Categories: Chinese Stocks, CNR, Webplus ver|Tags: , , , , , |0 Comments

CBPO [China Biologic Products] 10-Q/A: FORM 10-Q/A (Amendment No. 1) (Mark One) x

[FORM 10-Q/A (Amendment No. 1) (Mark One) x For the quarterly period ended: March 31, 2010 o For the transition period from ____________ to _____________ CHINA BIOLOGIC PRODUCTS, INC. Delaware 75-2308816 (State or other jurisdiction of incorporation (I.R.S. Employer Identification No.) or organization) No. 14 East Hushan Road Tai’an City, Shandong 271000 People’s Republic of China (+86) 538-620-2306 (Former name,] [CERTIFICATIONS I, Chao Ming Zhao, certify that: 1. I have reviewed this quarterly report on Form 10-Q/A of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [CERTIFICATIONS I, Y. Tristan Kuo, certify that: 1. I have reviewed this quarterly report on Form 10-Q/A of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.] [2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. (Principal Financial and Accounting Officer)]

CNR [CHINA METRO-RURAL] FWP: (Original Filing)

[Issuer Free Writing Prospectus, Dated May 6, 2011 Relating to the Preliminary Prospectus Supplement Dated May 5, 2011 and Registration Statement No. 333-171825 1,517,978 UNITS China Metro-Rural Holdings Limited May 6, 2011 PRICING TERM SHEET Issuer: China Metro-Rural Holdings Limited. Underwriter: Maxim Group LLC (“Maxim”) is the Sole Underwriter. Securities: Use of Proceeds: For the acquisition of land use rights]

By | 2016-03-20T09:44:05+00:00 May 6th, 2011|Categories: Chinese Stocks, CNR, SEC Original|Tags: , , , , , |0 Comments

CBPO [China Biologic Products] 10-Q/A: (Original Filing)

[FORM 10-Q/A (Amendment No. 1) (Mark One) For the quarterly period ended: September 30, 2009 For the transition period from ____________ to _____________ CHINA BIOLOGIC PRODUCTS, INC. Delaware 75-2308816 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) No. 14 East Hushan Road Tai’an City, Shandong 271000 People’s Republic of China (+86) 538-620-2306 (Former name, former address] [CERTIFICATIONS I, Chao Ming Zhao, certify that: 1. I have reviewed this quarterly report on Form 10-Q/A of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [CERTIFICATIONS I, Y. Tristan Kuo, certify that: 1. I have reviewed this quarterly report on Form 10-Q/A of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.] [2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. (Principal Financial and Accounting Officer)]

CNR [CHINA METRO-RURAL] FWP: Issuer Free Writing Prospectus, Dated May 6, 2011

[Issuer Free Writing Prospectus, Dated May 6, 2011 Relating to the Preliminary Prospectus Supplement Dated May 5, 2011 and Registration Statement No. 333-171825 1,517,978 UNITS China Metro-Rural Holdings Limited May 6, 2011 PRICING TERM SHEET Issuer: China Metro-Rural Holdings Limited. Underwriter: Maxim Group LLC (“Maxim”) is the Sole Underwriter. Securities: Use of Proceeds: For the acquisition of land use rights]

By | 2016-03-20T09:45:28+00:00 May 6th, 2011|Categories: Chinese Stocks, CNR, Webplus ver|Tags: , , , , , |0 Comments

CBPO [China Biologic Products] 10-Q/A: (Original Filing)

[FORM 10−Q/A (Amendment No. 1) x o Commission File No. 000-5 CHINA BIOLOGIC PRODUCTS, INC. (Name of Small Business Issuer in Its Charter) DELAWARE 75-2308816 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) No. 14 East Hushan Road Taian City, Shandong People's Republic of China 271000 (+86) 538-620-2306 x o o o o Large accelerated filer] [CERTIFICATIONS I, Chao Ming Zhao, certify that: 1. I have reviewed this quarterly report on Form 10-Q/A of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [CERTIFICATIONS I, Y. Tristan Kuo, certify that: 1. I have reviewed this quarterly report on Form 10-Q/A of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [1. 2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.] [1. 2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. (Principal Financial and Accounting Officer)]

MR [Mindray Medical International] 20-F/A: TABLE OFNTENTS Page EXPLANATORY NOTE 1 2 3

[TABLE OFNTENTS Page EXPLANATORY NOTE 1 2 3 EX-101 INSTANCE DOCUMENT EX-101HEMA DOCUMENT EX-101LCULATION LINKBASE DOCUMENT EX-101 LABELS LINKBASE DOCUMENT EX-101 PRESENTATION LINKBASE DOCUMENT EX-101 DEFINITION LINKBASE DOCUMENT EXPLANATORY NOTE No other changes have been made to the Form 20-F. This Amendment does not reflect events that have occurred after the April8, 2011 filingte of]

GAGA [Le Gaga] S-8: (Original Filing)

[] [Our ref Direct tel Email JPT\657525\4511506v1 Le Gaga Holdings Limited 6 May 2011 Dear Sirs Le Gaga Holdings Limited — Registration Statement on Form S-8 “Registration Statement” “Shares” “Plans” We have examined the Registration Statement on Form S-8 to be filed by Le Gaga Holdings Limited, a Cayman Islands exempted company incorporated with limited liability (the • Le Gaga Holdings] [Consent of Independent Registered Public Accounting Firm The Board of Directors We consent to the use of our report dated September 7, 2010, with respect to the combined balance sheets of Le Gaga Holdings Limited and subsidiaries as of March 31, 2008, 2009 and 2010, and the related combined income statements, statements of comprehensive income, statements of changes in equity]

By | 2016-03-20T19:34:32+00:00 May 6th, 2011|Categories: Chinese Stocks, GAGA, SEC Original|Tags: , , , , , |0 Comments

CBPO [China Biologic Products] 10-Q/A: FORM 10−Q/A (Amendment No. 1) x o Commission

[FORM 10−Q/A (Amendment No. 1) x o Commission File No. 000-5 CHINA BIOLOGIC PRODUCTS, INC. (Name of Small Business Issuer in Its Charter) DELAWARE 75-2308816 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) No. 14 East Hushan Road Taian City, Shandong People's Republic of China 271000 (+86) 538-620-2306 x o o o o Large accelerated filer] [CERTIFICATIONS I, Chao Ming Zhao, certify that: 1. I have reviewed this quarterly report on Form 10-Q/A of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [CERTIFICATIONS I, Y. Tristan Kuo, certify that: 1. I have reviewed this quarterly report on Form 10-Q/A of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [1. 2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.] [1. 2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. (Principal Financial and Accounting Officer)]

Skip to toolbar